Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Intera Partners in connection with the investment in Yellow Elk
Mandate

Vinge advises Intera Partners in connection with the investment in Yellow Elk

January 15, 2025

Vinge has advised the Nordic private equity firm Intera Partners in connection with its investment in the AI and data analytics firm Yellow Elk.

Yellow Elk offers high-level expertise within data analytics and AI, spanning from data engineering to machine learning, presentation, analysis and broader advisory, including enterprise and data architecture as well as data-driven change. Founded in 2018, Yellow Elk has a turnover of SEK 150 million and employs around 90 professionals in data and analytics in Sweden. Yellow Elk has been recognized by Dagens Industri as a fast-growing “Gasell” company for the past three years.

The transaction is subject to regulatory approvals.

Vinge’s team consisted of Jonas Johansson, Egil Svensson and Helena Liljenberg (M&A), Helena Göransson and Karl-Gustaw Tobola (Banking and Finance), Mario Saad and Jacob Eberil (Commercial Agreements), Simon Söderholm and Agnes Pigg (Employment), Johan Gavelin (IP), Katja Häglund (IT and GDPR), Madelene Andersson and Sara Franson (Real Estate), Daniel Wendelsson, Martin Hammarskiöld and Lovisa Arpi (Regulatory).

Read the client’s press release.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025